Assessing treatment of neuroleptic malignant syndrome.
D000547:Amantadine / Q000627:therapeutic use; D001971:Bromocriptine / Q000627:therapeutic use; D003348:Cortisone / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D009459:Neuroleptic Malignant Syndrome / Q000188:drug therapy* / Q000523:psychology; D010880:Piperidines / Q000627:therapeutic use*
D010880:Piperidines; D001971:Bromocriptine; C009185:pridinol; D000547:Amantadine; D003348:Cortisone